Imprimis NJOF, LLC 2024-06-19 Health serious FDA
Health · FDA · Recall #FDA-D-0548-2024
Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL,… Recall
Issued June 19, 2024 · Imprimis NJOF, LLC
In June 2024, Imprimis NJOF, LLC recalled the Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Imprimis NJOF, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Imprimis NJOF, LLC
- Category
- Health
- Recall date
- June 19, 2024
- Units affected
- Not reported
- Sold at
- US Nationwide
- Recall number
- FDA-D-0548-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Imprimis NJOF, LLC has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.